Patent details

EP1197226 Title: AGENTS FOR AMELIORATING TROUBLES FOLLOWING CEREBROVASCULAR FAILURE AND INHIBITING PROGRESS THEREOF

Basic Information

Publication number:
EP1197226
PCT Application Number:
PCT/JP/2000/004830
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009463936
PCT Publication Number:
WO/2001/005428
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
AGENTS FOR AMELIORATING TROUBLES FOLLOWING CEREBROVASCULAR FAILURE AND INHIBITING PROGRESS THEREOF
French Title of Invention:
AGENTS DESTINES A AMELIORER LES TROUBLES CAUSES PAR UNE INSUFFISANCE CEREBROVASCULAIRE ET A INHIBER LEUR EVOLUTION
German Title of Invention:
MITTEL ZUR VERBESSERUNG DER ERKRANKUNGEN NACH ZEREBRALEN DURCHBLUTUNGSSTÖRUNGEN SOWIE ZUR VERHINDERUNG DEREN FORTSCHRITTENS
SPC Number:

Dates

Filing date:
19/07/2000
Grant date:
21/11/2007
EP Publication Date:
21/11/2007
PCT Publication Date:
25/01/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/04/2002
EP B1 Publication Date:
21/11/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/07/2008
Expiration date:
19/07/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/07/2000
 
 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka, Japan (JP)

Inventor

1

Name:
OJIMA Mami
Address:
Japan (JP)

2

Name:
KITAYOSHI Takahito
Address:
Japan (JP)

3

Name:
MIYAMOTO Masaomi
Address:
Japan (JP)

Priority

Priority Number:
20587799
Priority Date:
21/07/1999
Priority Country:
Japan (JP)

Classification

Main IPC Class:
A61K 45/00;
Filing date Document type Number of pages